BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• 

  Genetown

  Magenta Therapeutics Snags $52 Million to Advance Bone Marrow Transplant Medications

  Fresh off of striking a research deal with Ladenburg, Germany-based Heidelberg Pharma GmbH, Magenta Therapeutics secured $52 million.The funds will be used to advance Magenta’s portfolio of bone marrow transplant medications.

  April 9, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  AbbVie’s Arthritis Drug Dazzles in Phase III Trial

  AbbVie announced positive top-line data from its Phase III SELECT-COMPARE clinical trial of upadacitinib in moderate to severe rheumatoid arthritis.

  April 9, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  AstraZeneca Licenses NASH Drug from Ionis Worth a Potential $330+ Million

  Investors in Ionis Pharmaceuticals are happy this morning after the company announced it struck another licensing deal with AstraZeneca that has the potential to yield up to $330 million.

  April 9, 2018

   · 

  2 min read

   · 

  Alex Keown